Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer
- 1 August 1983
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 11 (1), 23-28
- https://doi.org/10.1007/bf00257411
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cisplatin disposition in children and adolescents with cancerCancer Chemotherapy and Pharmacology, 1981
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980
- Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.1979
- Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).1979
- Kinetics of cis‐dichlorodiammineplatinumClinical Pharmacology & Therapeutics, 1979
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- PLASMA-LEVELS AND URINARY-EXCRETION OF FILTERABLE PLATINUM SPECIES FOLLOWING BOLUS INJECTION AND IV INFUSION OF CIS-DICHLORODIAMMINEPLATINUM(II) IN MAN1978
- Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man.1974
- Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).1973
- Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. InfusionJournal of Pharmaceutical Sciences, 1970